Research Services Division

Deakin Research

Research Output for Olivia M Dean

Note: The 2012, 2013, 2014 publications have not been audited.

Jump to: Publications | Grants and Consultancies | HDR completions

Publications

2014 School of Medicine

Anderson, George*, Berk, Michael, Dean, Olivia, Moylan, Steven and Maes, Michael* (2014) Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications, CNS Drugs, vol. 28, Adis International, Aukland, New Zealand [C1]
ERA journal ID: 14724 – Scopus EID: 2-s2.0-84893462851
DRO entry for this publication

2013 School of Medicine

Berk, Michael, Dean, Olivia, Drexhage, Hemmo*, McNeil, John J.*, Moylan, Steven, O'Neil, Adrienne, Davey, Christopher G.*, Sanna, Livia and Maes, Michael* (2013) Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness, BMC medicine, vol. 11, pp. 1-17, BioMed Central, London, England [C1]
ERA journal ID: 40887 – Scopus EID: 2-s2.0-84875043693
Citation counts: Scopus - 2, Thomson - 9
DRO entry for this publication

Berk, Michael, Malhi, Gin S.*, Gray, Laura J. and Dean, Olivia M. (2013) The promise of N-acetylcysteine in neuropsychiatry, Trends in pharmacological sciences, vol. 34, no. 3, pp. 167-177, Elsevier, Oxford, England [C1]
ERA journal ID: 14872 – Scopus EID: 2-s2.0-84874652458
Citation counts: Scopus - 20, Thomson - 12
DRO entry for this publication

Das, Pritha*, Tanious, Michelle*, Fritz, Kristina*, Dodd, Seetal, Dean, Olivia M., Berk, Michael and Malhi, Gin S.* (2013) Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo, Australian and New Zealand journal of psychiatry, vol. 47, no. 4, pp. 347-354, SAGE Publications, London, England [C1]
ERA journal ID: 13069 – Scopus EID: 2-s2.0-84880562183
Citation counts: Scopus - 1, Thomson - 1
DRO entry for this publication

Dodd, Seetal, Maes, Michael, Anderson, George*, Dean, Olivia M., Moylan, Steven and Berk, Michael (2013) Putative neuroprotective agents in neuropsychiatric disorders, Progress in neuro-psychopharmacology and biological psychiatry, vol. 42, pp. 135-145, Elsevier Inc., United States [C1]
ERA journal ID: 14855 – Scopus EID: 2-s2.0-84873523102
Citation counts: Scopus - 12, Thomson - 9
DRO entry for this publication

O'Neil, Adrienne, Berk, Michael, Itsiopoulos, Catherine*, Castle, David*, Opie, Rachelle*, Pizzinga, Josephine, Brazionis, Laima*, Hodge, Allison*, Mihalopoulos, Cathrine, Chatterton, Mary Lou, Dean, Olivia M. and Jacka, Felice N. (2013) A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol, BMC psychiatry, vol. 13, pp. 1-7, BioMed Central, London, England [C1]
ERA journal ID: 13134 – Scopus EID: 2-s2.0-84876132602
Citation counts: Scopus - 3, Thomson - 2
DRO entry for this publication

Samuni, Y., Goldstein, S.*, Dean, O. M. and Berk, M. (2013) The chemistry and biological activities of N-acetylcysteine, Biochim biophys acta, vol. 1830, no. 8, pp. 4117-4129, Elsevier, Amsterdam, Netherlands [C1]
ERA journal ID: 36838 – Scopus EID: 2-s2.0-84877828545
Citation counts: Scopus - 26, Thomson - 18
DRO entry for this publication

Vieira da Silva Magalhaes, Pedro*, Dean, Olivia, Bush, Ashley I.*, Copolov, David L.*, Malhi, Gin S.*, Kohlmann, Kristy*, Jeavons, Susan*, Schapkaitz, Ian*, Anderson-Hunt, Murray* and Berk, Michael (2013) A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania, Australian and New Zealand journal of psychiatry, vol. 47, no. 6, pp. 564-568, Sage Publications, London, England [C1]
ERA journal ID: 13069 – Scopus EID: 2-s2.0-84880550606
DRO entry for this publication

Dean, O. M., Jeavons, S.*, Malhi, G.S.*, Cotton, S. M.*, Tanious, M.*, Kohlmann, K.*, Hewitt, K.*, Moss, K.*, Allwang, C.*, Schapkaitz, I.*, Robbins, J.*, Cobb, H.*, Dodd, S., Bush, AI* and Berk, M. (2013) Deserves a hearing? A case report of remitting tinnitus with N-acetyl cysteine, African journal of psychiatry, vol. 16, no. 4, pp. 238-239, In House Publishing, Johannesberg, South Africa [C2]
ERA journal ID: 13118 – Scopus EID: Not tagged
DRO entry for this publication

2012 School of Medicine

Berk, Michael, Dean, Olivia M., Cotton, Sue M.*, Gama, Clarissa S.*, Kapczinski, Flavio*, Fernandes, Brisa*, Kohlmann, Kristy*, Jeavons, Susan*, Hewitt, Karen*, Moss, Kirsteen*, Allwang, Christine*, Schapkaitz, Ian*, Cobb, Heidi*, Bush, Ashley I.*, Dodd, Seetal and Malhi, Gin S.* (2012) Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial, BMC medicine, vol. 10, no. 91, pp. 1-11, BioMed Central, London, England [C1]
ERA journal ID: 40887 – Scopus EID: 2-s2.0-84864930739
Citation counts: Scopus - 11, Thomson - 9
DRO entry for this publication

Dean, Olivia M., Bush, Ashley I.*, Copolov, David L.*, Kohlmann, Kristy*, Jeavons, Susan*, Schapkaitz, Ian*, Anderson-Hunt, Murray and Berk, Michael (2012) Effects of N-acetyl cysteine on cognitive function in bipolar disorder, Psychiatry and clinical neurosciences, vol. 66, no. 6, pp. 514-517, Wiley-Blackwell Publishing Asia, Richmond, Vic. [C1]
ERA journal ID: 13109 – Scopus EID: 2-s2.0-84867546256
Citation counts: Scopus - 3, Thomson - 3
DRO entry for this publication

Dean, Olivia M., Data-Franco, Joao*, Giorlando, Francesco* and Berk, Michael (2012) Minocycline : therapeutic potential in psychiatry, CNS Drugs, vol. 26, no. 5, pp. 391-401, Adis International Ltd, Auckland, New Zealand [C1]
ERA journal ID: 14724 – Scopus EID: 2-s2.0-84859971485
Citation counts: Scopus - 27, Thomson - 21
DRO entry for this publication

Magalhaes, P. V., Dean, O. M., Bush, A. I., Copolov, D. L.*, Weisinger, D., Malhi, G. S.*, Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M. and Berk, M (2012) Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder, Progress in neuro-psychopharmacology and biological psychiatry, vol. 37, no. 1, pp. 132-135, Elsevier Inc., Philadelphia, Pa. [C1]
ERA journal ID: 14855 – Scopus EID: 2-s2.0-84857794206
Citation counts: Scopus - 5, Thomson - 5
DRO entry for this publication

Dean, Olivia and Berk, Michael (2012) Editorial : Hardan AY, Fung LK, Libove RA et al. A randomized controlled pilot trial of oral N‑acetylcysteine in children with autism. Biol. Psychiatry doi:10.1016/j.biopsych.2012.01.014 (2012) (Epub ahead of print)., Clinical practice, vol. 9, no. 3, p. 244, Future Medicine Ltd, London, England [C4]
ERA journal ID: Not matching ERA journal list
DRO entry for this publication

Dean, Olivia M. and Berk, Michael (2012) A randomized controlled pilot trial of oral n-acetylcysteine in children with autism, Clinical practice, vol. 9, no. 3, p. 244, Future Medicine Ltd, London, England [C4]
ERA journal ID: Not matching ERA journal list
DRO entry for this publication

Dean, Olivia M., Bush, Ashley I.* and Berk, Michael (2012) Translating the rosetta stone of N-Acetylcysteine, Biological psychiatry, vol. 71, no. 11, pp. 935-936, Elsevier, Philadelphia, Pa. [C4]
ERA journal ID: 2318 – Scopus EID: 2-s2.0-84861040626
Citation counts: Scopus - 3, Thomson - 5
DRO entry for this publication

2012 External

Magalhaes, Pedro V. S.*, Dean, Olivia*, Andreazza, Ana Christina*, Berk, Michael* and Kapczinski, Flavio* (2012) Adjunctive antioxidants for bipolar disorder, The Cochrane collaboration, no. 10, pp. 1-11, John Wiley & Sons, Oxford, England [C1.1]
ERA journal ID: 15305 – Scopus EID: Not tagged
DRO entry for this publication

2011 School of Medicine

Berk, Michael, Dean, Olivia, Cotton, Sue M.*, Gama, Clarissa S.*, Kapczinski, Flavio*, Fernandes, Brisa S.*, Kohlmann, Kristy, Jeavons, Susan*, Hewitt, Karen, Allwang, Christine*, Cobb, Heidi*, Bush, Ashley I.*, Schapkaitz, Ian, Dodd, Seetal and Malhi, Gin S.* (2011) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression : an open label trial, Journal of affective disorders, vol. 135, no. 1-3, pp. 389-394, Elsevier BV, Amsterdam, Netherlands [C1]
ERA journal ID: 13088 – Scopus EID: 2-s2.0-80055010828
Citation counts: Scopus - 40, Thomson - 34
DRO entry for this publication

Magalhães, Pedro V., Dean, Olivia M., Bush, Ashley I., Copolov, David L.*, Malhi, Gin S.*, Kohlmann, Kristy*, Jeavons, Susan*, Schapkaitz, Ian, Anderson-Hunt, Murray and Berk, Michael (2011) N-acetylcysteine for major depressive episodes in bipolar disorder, Revista Brasileira de Psiquiatria, vol. 33, no. 4, pp. 374-378, Elsevier, Sao Paulo, Brazil [C1]
ERA journal ID: 13114 – Scopus EID: 2-s2.0-84855821800
Citation counts: Scopus - 25, Thomson - 23
DRO entry for this publication

2011 External

Berk, M.*, Kapczinski, F.*, Andreazza, A. C.*, Dean, O. M.*, Giorlando, F.*, Maes, M.*, Yücel, M.*, Gama, C. S.*, Dodd, S.*, Dean, B.*, Magalhães, P. V. S.*, Amminger, P*, McGorry, P.* and Malhi, G. S.* (2011) Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors, Neuroscience & biobehavioral reviews, vol. 35, no. 3, pp. 804-817, Pergamon, Oxford, England [C1.1]
ERA journal ID: 14481 – Scopus EID: 2-s2.0-78649938042
Citation counts: Scopus - 182, Thomson - 159
DRO entry for this publication

Berk, Michael*, Munib, Ahmed*, Dean, Olivia*, Malhi, Gin S.*, Kohlmann, Kristy*, Schapkaitz, Ian*, Jeavons, Sue*, Katz, Fiona*, Anderson-Hunt, Murray*, Conus, Philippe*, Hanna, Barbara*, Otmar, Renée*, Ng, Felicity*, Copolov, David L.* and Bush, Ashley I.* (2011) Qualitative methods in early-phase drug trials : data and methods from a trial of N-acetylcysteine in schizophrenia, Journal of clinical psychiatry, vol. 72, no. 7, pp. 909-913, Physicians Postgraduate Press, Memphis, Tenn. [C1.1]
ERA journal ID: 6370 – Scopus EID: 2-s2.0-78249290706
Citation counts: Scopus - 9, Thomson - 8
DRO entry for this publication

Dean, Olivia M.*, van den Buuse, Maarten*, Berk, Michael*, Copolov, David L.*, Mavros, Christine* and Bush, Ashley I.* (2011) N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats : relevance to schizophrenia and bipolar disorder, Neuroscience letters, vol. 499, no. 3, pp. 149-153, Elsevier Ireland, Clare, Ireland [C1.1]
ERA journal ID: 14536 – Scopus EID: 2-s2.0-79960084100
Citation counts: Scopus - 17, Thomson - 14
DRO entry for this publication

Dean, Olivia*, Giorlando, Frank* and Berk, Michael* (2011) N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action, Journal of psychiatry and neuroscience, vol. 36, no. 2, pp. 78-86, Canadian Medical Association, Ottowa, Canada [C1.1]
ERA journal ID: 13162 – Scopus EID: 2-s2.0-79953111745
Citation counts: Scopus - 85, Thomson - 70
DRO entry for this publication

Gerlach, Manfred*, Bartoszyk, Gerd D.*, Riederer, Peter*, Dean, Olivia* and van den Buuse, Maarten* (2011) Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease, Journal of neural transmission, vol. 118, no. 12, pp. 1733-1742, Springer, Amsterdam, The Netherlands [C1.1]
ERA journal ID: 14496 – Scopus EID: 2-s2.0-84855192614
Citation counts: Scopus - 7, Thomson - 6
DRO entry for this publication

Magalhães, P. V.*, Dean, O. M.*, Bush, A. I.*, Copolov, D. L.*, Malhi, G. S.*, Kohlmann, K.*, Jeavons, S.*, Schapkaitz, I.*, Anderson-Hunt, M.* and Berk, M.* (2011) N-acetyl cysteine add-on treatment for bipolar II disorder : a subgroup analysis of a randomised placebo-controlled trial, Journal of affective disorders, vol. 129, no. 1-3, pp. 317-320, Elsevier BV, Amsterdam, The Netherlands [C1.1]
ERA journal ID: 13088 – Scopus EID: 2-s2.0-79851512462
Citation counts: Scopus - 29, Thomson - 26
DRO entry for this publication

Magalhaes, Pedro V. S.*, Andreazza, Ana Cristina*, Berk, Michael*, Kapczinski, Flavio* and Dean, Olivia* (2011) Antioxidant treatments for schizophrenia, Cochrane database of systematic reviews, no. 1, pp. 1-13, John Wiley & Sons, Oxford, U. K. [C1.1]
ERA journal ID: 15305 – Scopus EID: Not tagged
DRO entry for this publication

Magalhães, Pedro V.*, Dean, Olivia M.*, Bush, Ashley I.*, Copolov, David L.*, Malhi, Gin S.*, Kohlmann, Kristy*, Jeavons, Susan*, Schapkaitz, Ian*, Anderson-Hunt, Murray* and Berk, Michael* (2011) Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder., Acta neuropsychiatrica, vol. 23, no. 2, pp. 87-88, Wiley Blackwell, Oxford, England [C1.1]
ERA journal ID: 13122 – Scopus EID: 2-s2.0-79952264977
Citation counts: Scopus - 7, Thomson - 7
DRO entry for this publication

Thompson, Jason*, Berk, Michael*, Dean, Olivia*, Kohlmann, Kristy*, Jeavons, Sue*, Bush, Ashley* and Copolov, David* (2011) Who’s left? Symptoms of schizophrenia that predict clinical trial dropout, Human psychopharmacology, vol. 26, no. 8, pp. 609-613, John Wiley & Sons Ltd, West Sussex, England [C1.1]
ERA journal ID: 6291 – Scopus EID: 2-s2.0-83855165077
Citation counts: Scopus - 1, Thomson - 1
DRO entry for this publication

2010 External

Berk, Michael*, Dodd, Seetal*, Dean, Olivia M.*, Kohlmann, Kristy*, Berk, Lesley* and Malhi, Gin S.* (2010) The validity and internal structure of the bipolar depression rating scale (BDRS): data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder, Acta neuropsychiatrica, vol. 22, no. 5, pp. 237-242, Wiley Blackwell, Oxford, England [C1.1]
ERA journal ID: 13122 – Scopus EID: 2-s2.0-77956530415
DRO entry for this publication

Choy, Kwok Ho Christopher*, Dean, Olivia M.*, Berk, Michael*, Bush, Ashley I.* and van den Buuse, Maarten* (2010) Effects of n-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats, European journal of pharmacology, vol. 649, no. 1-3, pp. 224-228, Elsevier, Amsterdam, The Netherlands [C1.1]
ERA journal ID: 14757 – Scopus EID: 2-s2.0-78049286777
Citation counts: Scopus - 17, Thomson - 16
DRO entry for this publication

Dean, Olivia*, Bush, Ashley I.*, Berk, Michael*, Copolov, David L.* and van den Buuse, Maarten* (2010) Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice, Pharmacology, biochemistry and behavior, vol. 97, no. 2, pp. 293-300, Elsevier, Philadelphia, Pa. [C1.1]
ERA journal ID: 14845 – Scopus EID: 2-s2.0-77957823232
Citation counts: Scopus - 7, Thomson - 5
DRO entry for this publication

Villagonzalo, Kristi-Ann*, Dodd, Seetal*, Dean, Olivia*, Gray, Kylie*, Tonge, Bruce* and Berk, Michael* (2010) Oxidative pathways as a drug target for the treatment of autism, Expert opinion on therapeutic targets, vol. 14, no. 12, pp. 1301-1310, Informa Healthcare, London, England [C1.1]
ERA journal ID: 14764 – Scopus EID: 2-s2.0-78249244490
Citation counts: Scopus - 15, Thomson - 13
DRO entry for this publication

Dean, Olivia* and Berk, Michael* (2010) The specificity of pathogenic oxidative stress in schizophrenia, in Unknown (ed.), ASC 2010 : Molecules to mind : 11th Biennial Australasian Schizophrenia Congress, p. A19, Royal Australian and New Zealand College of Psychiatrists, Sydney, N.S.W. [E3.1]
DRO entry for this publication

2009 External

Berk, Michael*, Jeavons, Sue*, Dean, Olivia M.*, Dodd, Seetol*, Moss, Kirsteen*, Gama, Clarissa S.* and Malhi, Gin S.* (2009) Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting, CNS spectrums, vol. 14, no. 7, pp. 357-360, MBL Communications, New York, N.Y. [C1.1]
ERA journal ID: 13136 – Scopus EID: 2-s2.0-70350445015
Citation counts: Scopus - 19, Thomson - 12
DRO entry for this publication

Bernardo, Michelle*, Dodd, Seetal*, Gama, Clarissa S.*, Copolov, David L.*, Dean, Olivia*, Kohlmann, Kristy*, Jeavons, Susan*, Schapkaitz, Ian*, Anderson-Hunt, Murray*, Bush, Ashley I.* and Berk, Michael* (2009) Effects of N-acetylcysteine on substance use in bipolar disorder : a randomized placebo controlled clinical trial, Acta neuropsychiatrica, vol. 21, no. 5, pp. 239-245, Wiley Blackwell, Oxford, England [C1.1]
ERA journal ID: 13122 – Scopus EID: 2-s2.0-70349304388
Citation counts: Scopus - 1, Thomson - 2
DRO entry for this publication

Dean, O. M.*, van den Buuse, M.*, Bush, A. I.*, Copolov, D. L.*, Ng, F.*, Dodd, S.* and Berk, M.* (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice., Current medicinal chemistry, vol. 16, no. 23, pp. 2965-2976, Bentham Science Publishers, Schiphol, The Netherlands [C1.1]
ERA journal ID: 15238 – Scopus EID: 2-s2.0-70349404318
Citation counts: Scopus - 40, Thomson - 35
DRO entry for this publication

Dean, Olivia*, Bush, Ashley I.*, Berk, Michael*, Copolov, David L.* and van den Buuse, Maarten* (2009) Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice, Behavioural brain research, vol. 198, no. 1, pp. 258-262, Elsevier, Amsterdam, The Netherlands [C1.1]
ERA journal ID: 14483 – Scopus EID: 2-s2.0-58549098713
Citation counts: Scopus - 26, Thomson - 26
DRO entry for this publication

Bush, Ashley*, Dean, Olivia*, Copolov, D. L.* and Berk, M.* (2009) Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder, in Unknown (ed.), WFSBP Congress 2009 : Proceedings of the 9th World Congress of Biological Psychiatry, World Federation of Societies of Biological Psychiatry [EN.1]
DRO entry for this publication

2008 External

Berk, Michael*, Ng, Felicity*, Dean, Olivia*, Dodd, Seetal* and Bush, Ashley I.* (2008) Glutathione : a novel treatment target in psychiatry, Trends in pharmacological sciences, vol. 29, no. 7, pp. 346-351, Elsevier, London, England [C1.1]
ERA journal ID: 14872 – Scopus EID: 2-s2.0-45849098291
Citation counts: Scopus - 87, Thomson - 77
DRO entry for this publication

Berk, Michael*, Copolov, David*, Dean, Olivia*, Lu, Kristy*, Jeavons, Sue*, Schapkaitz, Ian*, Anderson-Hunt, Murray*, Judd, Fiona*, Katz, Fiona*, Katz, Paul*, Ording-Jespersen, Sean*, Little, John*, Conus, Philippe*, Cuenod, Michel*, Do, Kim Q.* and Bush, Ashley I.* (2008) N-Acetyl cysteine as a glutathione precursor for schizophrenia : a double blind, randomized, placebo-controlled trial, Biological psychiatry, vol. 64, no. 5, pp. 361-368, Elsevier, Philadelphia, Pa. [C1.1]
ERA journal ID: 2318 – Scopus EID: 2-s2.0-48749112603
Citation counts: Scopus - 182, Thomson - 154
DRO entry for this publication

Berk, Michael*, Copolov, David L.*, Dean, Olivia*, Lu, Kristy*, Jeavons, Sue*, Schapkaitz, Ian*, Anderson-Hunt, Murray* and Bush, Ashley I.* (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder - a double blind, randomized, placebo-controlled trial, Biological psychiatry, vol. 64, no. 6, pp. 468-475, Elsevier, Philadelphia, Pa. [C1.1]
ERA journal ID: 2318 – Scopus EID: 2-s2.0-49749109893
Citation counts: Scopus - 177, Thomson - 152
DRO entry for this publication

Dodd, Seetal*, Dean, Olivia*, Copolov, David L.*, Malhi, Gin S.* and Berk, Michael* (2008) N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility, Expert opinion on biological therapy, vol. 8, no. 12, pp. 1955-1962, Informa Healthcare, London, England [C1.1]
ERA journal ID: 14763 – Scopus EID: 2-s2.0-57649148545
Citation counts: Scopus - 108, Thomson - 92
DRO entry for this publication

Ng, Felicity*, Berk, Michael*, Dean, Olivia* and Bush, Ashley I.* (2008) Oxidative stress in psychiatric disorders : evidence base and therapeutic implications, International journal of neuropsychopharmacology, vol. 11, no. 6, pp. 851-876, Cambridge University Press, Cambridge, England [C1.1]
ERA journal ID: 14777 – Scopus EID: 2-s2.0-50849139232
Citation counts: Scopus - 260, Thomson - 211
DRO entry for this publication

2007 External

Berk, Michael*, Bush, Ashley*, Copolov, David*, Dean, Olivia*, Lu, Kristy*, Katz, Paul*, Schapkaitz, Ian*, Anderson-Hunt, Murray*, Judd, Fiona* and Cuenod, Michel* (2007) N-acetyl cysteine as a glutathione precursor for schizophrenia : a double-blind, randomised, placebo-controlled trial, in Unknown (ed.), WPA 2007 : Working together for mental health: Partnerships for policy and practice : World Psychiatric Association International Congress, World Psychiatric Association [E3.1]
DRO entry for this publication

Dean, Olivia M.*, Bush, Ashley I.*, van den Buuse, Maarten*, Copolov, David L.* and Berk, Michael* (2007) Glutathione depletion in animal models of psychiatric disorders, Proceedings of the Australasian Society for Bipolar Disorders Conference 2007, p. 1, John Wiley & Sons [E3.1]
DRO entry for this publication

Dean, Olivia*, van den Buuse, Maarten*, Berk, Michael*, Copolov, David* and Bush, Ashley* (2007) Glutathione depletion as an animal model of schizophrenia, in Unknown (ed.), WPA 2007 : Working together for mental health : partnerships for policy and practice : Proceedings of the 2007 World Psychiatry Congress, p. A244, World Psychiatry Congress, Melbourne, Vic. [E3.1]
DRO entry for this publication

Dean, O. M.*, Bush, A. I.*, Berk, M.*, Copolov, D. L.* and van den Buuse, M.* (2007) Role of glutathione in schizophrenia? The effect of brain glutathione depletion on prepulse inhibition (PPI) in rats and mice, in Unknown (ed.), Neuroscience 2007 : The 37th annual meeting of the Society for Neuroscience, Society for Neuroscience, Washington, D. C. [EN.1]
DRO entry for this publication

2006 External

Bernardo, M.*, Berk, M.*, Dodd, S.*, Lu, K.*, Dean, Olivia*, Schapkaitz, I.* and Jeavons, S.* (2006) The clinical global impressions scale modified for substance use (CGI-SU) in patients with bipolar disorder, Acta neuropsychiatrica, vol. 18, no. 6, pp. 278-279, Wiley Blackwell, Oxford, England [CN.1]
ERA journal ID: 13122 – Scopus EID: Not tagged
DRO entry for this publication

2005 External

Dean, Olivia M.*, Copolov, David L.*, Berk, Michael*, Bush, Ashley* and van den Buuse, Maarten* (2005) Brain glutathione depletion as an animal model with relevance to schizophrenia : 2-cyclohexene-1-one (CHX) dose-response studies, in Unknown (ed.), CINP/ASPR 2005 : Proceedings of the 2005 Royal Australian and New Zealand College of Psychiatrists Joint CINP/ASPR scientific meeting, pp. A65-A66, RANZCP, Brisbane, Qld. [E3.1]
DRO entry for this publication

Dean, Olivia* (2005) Brain glutathione depletion as an animal model with relevance to schizophrenia: 2-cyclohexene-1-one (CHX) dose-response studies, in unknown (ed.), ANS 2005 : Australian Neuroscience Society Conference proceedings, Australian Neuroscience Society, Perth, W.A. [EN.1]
DRO entry for this publication

Dean, O. M.*, Bush, A.*, Berk, M.*, Copolov, D.* and Van den Buuse, M.* (2005) Brain glutathione depletion as an animal model with relevance to schizophrenia : 2-cyclohexene-1-one dose-response studies and treatment with N-acetyl cysteine, in Unknown (ed.), Society for Neuroscience 35th Annual Meeting, p. 1, Society for Neuroscience, Washington, D.C. [EN.1]
DRO entry for this publication

Dean, Olivia*, Copolov, David L.*, Berk, Michael*, Bush, Ashley* and van den Buuse, Maarten* (2005) Brain glutathione depletion as an animal model with relevance to schizophrenia : 2-cyclohexene-1-one (CHX) dose-response studies, in Unknown (ed.), Abstracts of the Royal Australian and New Zealand College of Psychiatrists Joint CINP/ASPR Scientific Meeting [EN.1]
DRO entry for this publication

2004 External

Jespersen, Sean*, Berk, Michael*, Van Wyk, Caren*, Dean, Olivia*, Dodd, Seetal*, Szabo, Christopher P.* and Maud, Catherine* (2004) A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use, International clinical psychopharmacology, vol. 19, no. 3, pp. 161-164, Lippincott Williams & Wilkins, Philadelphia, Pa. [C1.1]
ERA journal ID: 14773 – Scopus EID: Not tagged
DRO entry for this publication

Dean, O.*, van den Buuse, M.*, Copolov, D.*, Berk, M.* and Bush, A.* (2004) N-acetyl-cysteine treatment inhibits depletion of brain glutathione levels in rats : implications for schizophrenia, International journal of neuropsychopharmacology, vol. 7, no. Supplement 2, p. S262, Cambridge University Press, Cambridge, U.K. [C2.1]
ERA journal ID: 14777 – Scopus EID: Not tagged
DRO entry for this publication

Jespersen, S.*, Berk, M.*, van Wyk, C.*, Dean, O.*, Dodd, S.*, Szabo, C.* and Maud, C.* (2004) A pilot randomised, double-blind, placebo controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use, International journal of neuropsychopharmacology, vol. 7, no. Supplement 2, pp. S342-S343, Cambridge University Press, Cambridge, England [C2.1]
ERA journal ID: 14777 – Scopus EID: Not tagged
DRO entry for this publication

Grants and Consultancies

All years

Research Income - National Competitive Grants

Berk, M*, Malhi, G*, Dodd, S* and Dean, O*. The Efficacy of N-acetylcysteine as an adjunctive treatment in unipolar depression, NHMRC Project Grant [T]

  • 2012: $32,726
  • 2011: $48,925

Berk, M*, Dean, O*, Cotton, S*, Dodd, S, Malhi, G* and Ng, C*. The Efficacy of N-acetylcysteine as an Adjunctive Treatment in Bipolar Depression: A Double-blind, Randomised, Placebo-controlled Trial, NHMRC Project Grant [T]

  • 2012: $197,858

Berk, M*, Chanen, A*, Harrigan, S*, Davey, C, Hetrick, S*, Dean, O and Dodd, S. Proof of principle of the inflammatory and oxidative theory of depression: A treatment study, NHMRC Project Grant [T]

  • 2012: $26,547

Research Income - Industry and Other Funding - Australian

Dean, O. The Efficacy of Minocycline as an Adjunctive Treatment in Unipolar Depression: A Pilot Study [V.1]

  • 2012: $10,000

Research Income - Industry and Other Funding - International B (Other Income)

Berk, M, Dodd, S, Dean, O, Gray, K* and Tonge, B*. Efficacy of N-Acetyl Cysteine in Autism: A double blind, placebo-controlled randomised trial [V.3]

  • 2012: $119,641

Higher Degree by Research Completions supervised by Olivia M Dean

No completions found or audited.

Legend:
* Not a member of Deakin University at time of output.

DRO to publications collection last synchronised: Sunday 13th July 2014 10:04pm

Deakin University acknowledges the traditional land owners of present campus sites.

23rd July 2011